Articles tagged with Macrophages
A new study published in the Journal of Leukocyte Biology suggests that simvastatin impairs immune cells' ability to kill pathogens and enhances inflammation. Researchers found that simvastatin also increases cytokine production, which triggers and sustains inflammation.
Researchers at Johns Hopkins Medicine have identified a key protein, TRPV2, that plays a crucial role in helping macrophages capture and destroy germs. The protein helps macrophages bind to bacteria more effectively, which enables the immune system to clear infections more efficiently.
Researchers at Gladstone Institute of Cardiovascular Disease discovered that DGAT1, an enzyme involved in fat storage, protects against diet-induced inflammation and insulin resistance. Enhancing DGAT1's capacity in macrophages may hold therapeutic promise for preventing obesity-related diseases.
Researchers have made significant progress in understanding the relationship between cholesterol and heart disease, finding that it's not just one factor at play but rather a complex interplay of immune cells and proteins. The study highlights the importance of restoring the balance of this network to prevent vascular disease.
Researchers identify potential new targets for preventing early loss of transplanted pancreatic islets, which could improve the efficiency of pancreatic islet transplantation. Meanwhile, studies show that engineering macrophages to store triacylglycerol protects mice from diet-induced insulin resistance and inflammation.
Aged mice treated with a macrophage-specific growth factor exhibit enhanced resistance to bacterial infection, indicating potential therapeutic strategies for healthy aging. The study's findings provide insight into the underlying immune dysfunction contributing to age-related increased susceptibility to infections.
Researchers have identified a new therapeutic approach for proliferative crescentic disease, a type of advanced kidney disease associated with lupus. The study suggests targeting macrophages and growth factors involved in the disease mechanism.
Researchers found that tumor-associated macrophages produce high levels of proteases cathepsin B and S, enhancing tumor growth and invasion. Interleukin-4 stimulation by tumors stimulates increased Cts B and S activity, providing a potential therapeutic target.
Researchers found that macrophages along the blood-brain barrier can either activate the brain's stress response machinery or prevent excessive inflammation. This discovery may pave the way for novel therapies for neurodegenerative diseases.
Researchers found that tubercle formation is a critical step in TB infection, and that epithelial cells produce MMP9 enzyme to recruit macrophages. Blocking this pathway may lead to new therapies for TB and other inflammatory conditions.
A new study suggests that a damaging inflammatory response following spinal cord injury can prevent healing and promote chronic pain. Anti-inflammatory macrophages, which are typically involved in later stages of injury repair, were found to promote effective growth of axons but disappear shortly after an injury.
Researchers at Stanford University School of Medicine have identified a cellular mechanism that causes lupus-like symptoms in mice. The study found that macrophages play a crucial role in disposing of dying cells, and a specific molecule called PPAR-delta helps regulate this process.
Researchers have uncovered the genetic switch that controls macrophage polarization, essential for muscles to regenerate properly. Macrophage polarization allows them to shift from clearing debris to promoting repair in damaged areas.
Researchers have identified new targets for treating breast cancer metastasis by inhibiting Brk protein expression. Additionally, a study on Wnk1 revealed its critical role in angiogenesis and heart development. Furthermore, drug abuse has been found to worsen HIV-associated neurocognitive disorders through dopamine signaling.
A study found that diabetics with low vitamin D levels can't process cholesterol normally, leading to increased blood vessel buildup and heart attack risk. Increasing vitamin D levels may slow or reverse atherosclerosis development, researchers suggest.
A new study published in PLOS Pathogens shows that Leishmania parasites use a gel to persuade immune cells called macrophages to feed them instead of killing them. This trick enables the parasites to establish an infection and infect the skin, highlighting a crucial step in leishmaniasis transmission.
Researchers at Albert Einstein College of Medicine have identified a distinct population of macrophages that may promote metastatic cancer growth. The study suggests that targeting these cells could inhibit tumor growth and potentially reduce cancer mortality.
Researchers at EMBL and University of Heidelberg create fluorescent probe to quantify MMP12 activity in macrophages, allowing study of emphysema development. The test has potential as biomarker for disease evolution and therapeutic intervention monitoring.
Research reveals that blood-derived macrophages with interleukin-10 expression have an anti-inflammatory effect on spinal cord injuries. This finding suggests that these cells may contribute to the recovery process after injury.
A subset of infiltrating monocyte-derived macrophages, expressing interleukin-10, exhibits an anti-inflammatory role in spinal cord injuries. This suggests that these cells may have a beneficial effect on recovery from such injuries.
Researchers at Stanford University Medical School have discovered that leukemia stem cells can escape detection by co-opting a protective molecular badge used by normal blood stem cells. The molecule, CD47, protects the leukemia stem cells from macrophages, allowing them to evade the immune system. Studies found that patients with high...
Researchers have discovered a protein on the surface of leukemia stem cells that helps them evade macrophage immune cells. Targeting this protein, called CD47, may help increase the body's appetite for killing cancer cells.
Researchers found that almost all HIV virus was packed into macrophages in diseased cells, which are immune cells that 'eat' invading disease agents. This discovery could lead to new treatments by targeting these infected macrophages.
Scientists find novel salt storage site in the skin and a gene regulator controlling blood pressure regulation. A high-salt diet leads to increased lymphatic vessels, but the process behind this storage and its relevance to human disease are not yet fully understood.
Researchers at UMass Chan Medical School describe a potent method to deliver therapeutic siRNA molecules orally, silencing genes in mice and showing promise for treating human diseases. The method uses yeast particles as a delivery shell, targeting specific cells and achieving gene silencing with minimal immune response.
Researchers found that macrophages focus reactive oxygen species (ROS) on targets outside the cytoplasm to kill bacteria. The study shows that superoxide dismutases in bacterial periplasm protect bacteria from ROS, suggesting a new mechanism for macrophage-bacteria interaction.
Researchers found that HAART contributes to pulmonary hypertension in HIV-infected patients by impairing blood vessel-lining endothelial cell function. A novel treatment for chronic hypoxic pulmonary hypertension (PHTN) involves neprilysin, which protects against PHTN by regulating neural signaling molecules.
Research found that Helicobacter pylori can multiply in autophagic vesicles within macrophages, increasing resistance to antibiotics and evading the immune system. This discovery has significant implications for understanding the life cycle of H. pylori and potential new drug targets.
Researchers at Vanderbilt University Medical Center have identified prostaglandin-E2 receptors as crucial players in atherosclerosis development. Mice with impaired EP4 receptors showed reduced atherosclerosis and increased macrophage programmed cell death, highlighting the importance of these signaling pathways in disease progression.
Researchers have developed a mouse model of neonatal diabetes that replicates human disease, providing new insight into the condition. Additionally, studies have identified a link between endothelial dysfunction and altered metabolic responses, particularly in relation to high-fat diets and glucose regulation.
The journal Cold Spring Harbor Protocols presents two articles detailing experimental culture methods for cells from the immune system and the nervous system. These protocols enable researchers to isolate and grow specialized cells like macrophages and cerebellar granule neurons, facilitating studies on their functions and interactions.
Researchers found that Mycobacterium tuberculosis uses foamy macrophage formation to survive in infected individuals. These 'foamy' cells provide a nutrient-rich reservoir for the bacteria, allowing it to persist in a dormant state.
A proteomics study has identified new proteins that facilitate communication between the immune system and the self-cleaning process, potentially leading to new treatments for tuberculosis. The research found that autophagy plays a crucial role in immune response, particularly against intracellular pathogens.
St. Jude researchers discover how intracellular pathogens use biochemical machinery to block nitric oxide production, a key chemical weapon against them. The findings offer hints for fighting bacteria and suggest the development of targeted drugs to inhibit such diseases as tuberculosis and toxoplasmosis.
Researchers found a protein called TREM-2 in the spinal fluid of MS patients, suggesting it may be contributing to the disease. The protein's presence could lead to new pharmaceutical targets for MS prevention and treatment.
Researchers identified A2BAR as a potential therapeutic target for acute lung injury, which spontaneously resolves in some individuals. Additionally, human immune cells' secreted proteins enhance the clearance of bacteria by other immune cells, offering a new mechanism for bacterial infections.
Scientists have discovered a previously unknown molecular signaling pathway in body fat cells that normally acts to suppress harmful inflammation, but is overridden by obesity. The protective function can be boosted with drugs targeting PPAR-d, potentially treating insulin resistance and diabetes.
Researchers found that interrupting a signaling pathway in immune system cells opened the possibility of a new strategy against Alzheimer's disease. Immune cells from outside the brain devoured plaque deposits, reducing their numbers by up to 90 percent.
A team of scientists discovered that Vpx protein enables the AIDS virus to reproduce by facilitating reverse transcription in the simian virus life-cycle. The findings are significant as they suggest potential new strategies to prevent replication.
New study identifies IKK(beta) protein as key driver of pro-tumor switch in macrophages, which halts production of anti-tumor genes. Inactivating IKK(beta) reprograms macrophages into tumor killers, attracting professional immune cells to shrink tumors.
Researchers at the University of British Columbia have discovered how tuberculosis bacteria hide and multiply in human bodies. By identifying a key protein involved in this process, they are working towards therapies that can block its activity, leading to a more effective treatment for TB.
Researchers identified a key mechanism by which macrophages recognize friendly cells, preventing them from being eaten. This discovery could lead to new treatments for inflammatory diseases such as arthritis and atherosclerosis.
Researchers at UCF have identified a new protein family that regulates macrophage activation, potentially leading to the development of treatments for inflammatory diseases. The discovery has implications for conditions such as cardiovascular disease, cancer, and obesity-induced type 2 diabetes.
Researchers found a way to reverse HIV's deadly longevity by targeting its chemical changes that keep reservoirs alive. An existing ant-parasite drug, miltefosine, inhibits the PI3K/Akt pathway, which enables macrophages to survive despite surrounding toxicity.
Researchers have discovered a weakness in the defenses of the anthrax bacterium that could be exploited to produce new antibiotics. Nitric oxide is a critical part of Bacillus anthracis's defense against the immune response, and disrupting this system could make it vulnerable to attack by macrophages.
A research team at Weill Cornell Medical College identified two genes, Pbx-1 and Prep-1, that play a critical role in regulating interleukin-10 (IL-10) production. This discovery could lead to new avenues for understanding and treating diseases such as lupus, cancer, and HIV/AIDS.
Researchers at St. Jude Children's Research Hospital have found a connection between two cellular defense mechanisms, phagocytosis and autophagy, that help the body fight infections and resist chemotherapy drugs. The study suggests that these mechanisms work together to destroy germs and cancer cells, paving the way for new treatments.
Anthony Azenabor's research reveals that Chlamydia bacteria can manipulate macrophage cell walls, causing atherosclerosis and disrupting hormone production in the placenta. This discovery could lead to new treatments for both heart disease and infertility by blocking cholesterol signaling.
Scientists discovered that regulatory T cells can reverse macrophages' role in causing inflammation, allowing tumors to go undetected by the body's natural defenses. This knowledge may lead to new treatments for tumors and could also be applied to block chronic inflammation in conditions like rheumatoid arthritis.
Scientists discovered that immune cells called macrophages play a role in age-related macular degeneration by failing to block abnormal blood vessel formation. In older mice, macrophages shift from M1 to M2 type, promoting disease progression.
Researchers at MIT discovered a link between gene SIRT1 and cholesterol flushing pathway, which could lead to drugs lowering risk of diseases like atherosclerosis and Alzheimer's. Potential treatments based on polyphenols may be developed to enhance SIRT1 effects.
A multidisciplinary team of researchers at Columbia University Medical Center will investigate the link between type 2 diabetes and heart disease using a $10.8 million NIH grant. They aim to understand how insulin resistance contributes to accelerated atherosclerotic lesion progression in diabetics.
A study published in JCI found that bacteria residing in the gut boost immune response to tumors after total body irradiation, a common treatment for cancer. The researchers discovered that a specific population of bacteria plays a crucial role in augmenting the function of tumor-specific T cells and resulting in tumor regression.
Immune cells use filopodia to catch pathogens, with the internal scaffolds growing and shrinking through actin filaments. Researchers tracked the dynamic behavior of these structures for the first time in three dimensions, revealing discrete steps of retraction and a possible molecular mechanism underlying it.
A study published in The American Journal of Pathology found that a specific enzyme helps protect against tumor growth by enhancing the immune response. Mice with high levels of this enzyme in their macrophages were resistant to melanoma and lymphoma, demonstrating its potential as a new cancer therapy.
A Stanford study found that macrophages, known as troublemakers in obesity, can also play a beneficial role in metabolism. The researchers identified a molecular switch that can shift the cells into the more desirable mode, which could help block insulin resistance and type-2 diabetes.
Researchers at Mount Sinai School of Medicine have developed a new imaging technology using multi-detector computed tomography (CT) and a novel contrast agent N1177 to detect high-risk plaque. This may help physicians diagnose a heart attack before it occurs, preventing cardiac events.
Macrophages play a critical role in clearing debris after nerve damage, but their continued presence can damage tissue and compromise repair. Now, researchers have identified a process that allows macrophages to be cleared, enabling nerve regeneration.
Researchers used MRI to detect macrophages in arterial walls, which indicate inflammation and cardiovascular disease. The study found a 79% increase in detection compared to baseline images, suggesting a potential noninvasive screening tool for heart attack risk.
A genetic mutation in the beta1-adrenergic receptor alters the response to certain heart failure drugs, highlighting the potential for personalized medicine. The study found that a single amino acid change in the receptor can affect how well patients respond to beta blockers, with some variants showing increased sensitivity to carvedilol.